Condition

High Blood Sugar

ClinicalTrials.gov condition label

Clinical trials8

Recruiting1

Common interventions9

Lead sponsors shown5

Clinical trials

8 shown

Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot StudyNCT06555393 · 2026-02-25

A Virtual Cardiometabolic Health Program for African Immigrants: The Afro-DPP ProgramNCT05144737 · 2021-11-21

CGM Use in Poorly Controlled Youth With Type 1 DiabetesNCT04721145 · 2021-01-25

Comparative Effectiveness of Family vs. Individually Focused Diabetes Education and SupportNCT03812614 · 2019-09-23

Habitual Diet and Avocado TrialNCT03528031 · 2018-06-19

Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes MellitusNCT01294423 · 2011-02-01

Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes MellitusNCT01294436 · 2011-02-01

A Relative Bioavailability Study Measuring the Extent and Rate of Absorption of Different Tablet Formulations of AZD1656 in Type 2 Diabetes Mellitus (T2DM) PatientsNCT01221519 · 2010-09-01

Common interventions

DapagliflozinDRUG2 AZD1656DRUG1 Dexcom G6 Continuous Glucose MonitorDEVICE1 Egg White PowderDIETARY_SUPPLEMENT1 FAM ACTBEHAVIORAL1 I-DSMESBEHAVIORAL1 Intervention Daily AvocadoOTHER1 PlaceboDRUG1 The Diabetes Prevention ProgramBEHAVIORAL1

Leading sponsors

AstraZeneca3 Johns Hopkins University2 University of Alberta1 University of Pittsburgh1 Wake Forest University Health Sciences1

Trial status mix

COMPLETED7

RECRUITING1

Phase mix

NA4

PHASE12

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.